三達膜(688101.SH):2021年度擬申請不超3億元綜合授信額度
格隆匯12月14日丨三達膜(688101.SH)公佈,2021年度公司及全資子公司擬向銀行等金融機構申請不超過3.00億元的綜合授信額度。
為滿足公司生產經營和業務發展的資金需求,提高公司決策效率,公司擬為全資子公司三達膜科技就上述綜合授信額度內的融資提供不超過人民幣1.55億元的擔保額度,擔保方式為連帶責任保證,具體擔保期限根據屆時簽訂的擔保合同為準。
由於集美融資擔保對公司全資子公司三達膜科技在上述授信額度內提供人民幣1500.00萬元連帶責任保證。為支持全資子公司三達膜科技經營發展及其確保債務的履行,應擔保公司的要求,公司就上述擔保提供反擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.